![Steven Theriault](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Theriault
Vorstandsvorsitzender bei CYTOPHAGE TECHNOLOGIES LTD.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Steven Theriault
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYTOPHAGE TECHNOLOGIES LTD. | Direktor/Vorstandsmitglied | 08.02.2024 | - |
Vorstandsvorsitzender | 08.02.2024 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 08.02.2024 | - |
Karriereverlauf von Steven Theriault
Ehemalige bekannte Positionen von Steven Theriault
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cytophage Technologies, Inc. (Old)
![]() Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Vorstandsvorsitzender | 01.01.2017 | - |
Corporate Officer/Principal | 01.01.2017 | - |
Statistik
International
Kanada | 2 |
2 |
Operativ
Chief Executive Officer | 2 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cytophage Technologies, Inc. (Old)
![]() Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Health Technology |
Cytophage Technologies Ltd. |
- Börse
- Insiders
- Steven Theriault
- Erfahrung